Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

8.5%

50 terminated/withdrawn out of 585 trials

Success Rate

82.1%

-4.4% vs industry average

Late-Stage Pipeline

11%

62 trials in Phase 3/4

Results Transparency

1 of 230 completed trials have results

Key Signals

127 recruiting1 with results16 terminated34 withdrawn

Enrollment Performance

Analytics

N/A

269(76.6%)

Phase 3

48(13.7%)

Phase 2

18(5.1%)

Phase 4

14(4.0%)

Early Phase 1

2(0.6%)

351Total

N/A(269)

Phase 3(48)

Phase 2(18)

Phase 4(14)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (585)

Showing 20 of 585 trials

NCT07559344Not ApplicableRecruiting

Effects of Hot Baths Prior or After a Damaging Protocol on Muscle Function and HSP70 Expression

Role: lead

NCT07557550Not ApplicableRecruiting

Comparison of Two Relaxation Strategies Between Glasses, Virtual Reality Headset, and Without Relaxation Tool, in the Anxiety Preoperative of Orthopedic Adult Patients

Role: lead

NCT02121730Completed

Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy Regions

Role: lead

NCT02392221Completed

Impact of Therapeutic Strategies in the Pediatric Inflammatory Bowel Disease: a Population Based Study (1988-2011).

Role: lead

NCT02799225Completed

Prevalence of Clinical Strains of Enterobacteria With Reduced Susceptibility to Carbapenems in the North-West Region of France

Role: lead

NCT07540429Not ApplicableRecruiting

ADOLESCENTS IMAGING USING fMRI: Feasibility Study

Role: collaborator

NCT07210671Recruiting

Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous